VRDN Viridian Therapeutics notches narrow Q4 2025 EPS beat but shares fall 358 percent on lukewarm investor sentiment First Trust Natural Gas ETF FCG 2026 Performance Review and Investment Suitability Analysis Pimco PCN Stock Gap Up Watch Eye on Rally 20260427